Lista de obras - Sara Heebøll - Dominio Público Uruguay

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

artículo científico publicado en 2016

Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.

artículo científico publicado en 2015

Effect of resveratrol on experimental non-alcoholic steatohepatitis.

artículo científico publicado en 2015

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

artículo científico publicado en 2014

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

artículo científico publicado en 2009

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.

artículo científico publicado en 2018

Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

artículo científico publicado en 2019

Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

artículo científico publicado en 2016

Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer

artículo científico publicado en 2015

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis

artículo científico publicado en 2018

Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience.

artículo científico publicado en 2013

Prostate cancer: to scan or not to scan for lymph node involvement?

scientific article published on 01 January 2007

Smarcc1 expression: a significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure.

artículo científico publicado en 2010

Snail1 is over-expressed in prostate cancer

artículo científico publicado en 2009

Urea cycle dysregulation in non-alcoholic fatty liver disease

artículo científico publicado en 2018

[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]

scientific article published on 01 February 2012

[Treatment of non-alcoholic fatty liver disease] ⬇️

scientific article published on 01 July 2018

Lista de obras de Sara Heebøll

Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment.

Effect of resveratrol on experimental non-alcoholic steatohepatitis.

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.

Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease

Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis

Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience.

Prostate cancer: to scan or not to scan for lymph node involvement?

Smarcc1 expression: a significant predictor of disease-specific survival in patients with clinically localized prostate cancer treated with no intention to cure.

Snail1 is over-expressed in prostate cancer

Urea cycle dysregulation in non-alcoholic fatty liver disease

[Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis]

[Treatment of non-alcoholic fatty liver disease] ⬇️